Apatinib as Salvage Treatment in BRCA2-Mutated Advanced Lung Adenocarcinoma

Am J Ther. 2019 Nov/Dec;26(6):e747-e748. doi: 10.1097/MJT.0000000000000905.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma of Lung / drug therapy*
  • Adenocarcinoma of Lung / genetics
  • Genes, BRCA2*
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / genetics
  • Male
  • Middle Aged
  • Mutation*
  • Pyridines / therapeutic use*
  • Salvage Therapy

Substances

  • Pyridines
  • apatinib